Outcome of HSCT in Children at Ramathibodi Hospital

Brief summary (registry, in English)

Firstly, to study the treatment outcomes of hematopoietic stem cell transplantation (HSCT) in patients with hematologic diseases, cancers, and other conditions treated at the Department of Pediatrics, Faculty of Medicine Ramathibodi Hospital. Secondly, to evaluate factors that may influence treatment outcomes in patients with hematologic diseases, cancers, and other conditions undergoing hematopoietic stem cell transplantation. Lastly, to study complications occurring after hematopoietic stem cell transplantation in patients with hematologic diseases, cancers, and other conditions, in order to identify opportunities to further improve treatment outcomes.

What you commit to

• Study type: Observational
• Planned participants: 200
• From 8 May 2020 to the primary completion date, 7 May 2030
• 1 site in 1 country
• Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Who the study is looking for

Age in the registry: - to 18 years · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.